Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 128 of 128 entries
Sorted by: Best Match Show Resources per page
A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed.

Diabetologia

Speight J, Skinner TC, Huber JW, Lake AJ, Messina R, Mocan A, Nefs G, Newson L, Povey R, Vallis M, Willaing I.
PMID: 34778926
Diabetologia. 2022 Feb;65(2):406-408. doi: 10.1007/s00125-021-05615-z. Epub 2021 Nov 15.

No abstract available.

Cite
Speight J, Skinner TC, Huber JW, et al. A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed. Diabetologia. 2021;65(2):406-408doi: 10.1007/s00125-021-05615-z.
Speight, J., Skinner, T. C., Huber, J. W., Lake, A. J., Messina, R., Mocan, A., Nefs, G., Newson, L., Povey, R., Vallis, M., Willaing, I. (2022). A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed. Diabetologia, 65(2), 406-408. https://doi.org/10.1007/s00125-021-05615-z
Speight, Jane, et al. "A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed." Diabetologia vol. 65,2 (2022): 406-408. doi: https://doi.org/10.1007/s00125-021-05615-z
Speight J, Skinner TC, Huber JW, Lake AJ, Messina R, Mocan A, Nefs G, Newson L, Povey R, Vallis M, Willaing I. A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed. Diabetologia. 2022 Feb;65(2):406-408. doi: 10.1007/s00125-021-05615-z. Epub 2021 Nov 15. PMID: 34778926.
Copy Download .nbib Format: NLM
TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS).

Journal of wildlife diseases

Buchanan C, Woolford L, Stephenson T, Hoebergen M, Kovac JH, Breed WG, Speight N.
PMID: 34797903
J Wildl Dis. 2022 Jan 01;58(1):158-167. doi: 10.7589/JWD-D-21-00055.

Testis asymmetry, in which the testes in an individual differ in size, has recently been reported in koalas (Phascolarctos cinereus) in the Mount Lofty Ranges population of South Australia. We describe the morphology and histology of both testes from...

Cite
Buchanan C, Woolford L, Stephenson T, et al. TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). J Wildl Dis. 2022;58(1):158-167doi: 10.7589/JWD-D-21-00055.
Buchanan, C., Woolford, L., Stephenson, T., Hoebergen, M., Kovac, J. H., Breed, W. G., & Speight, N. (2022). TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). Journal of wildlife diseases, 58(1), 158-167. https://doi.org/10.7589/JWD-D-21-00055
Buchanan, Chloe, et al. "TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS)." Journal of wildlife diseases vol. 58,1 (2022): 158-167. doi: https://doi.org/10.7589/JWD-D-21-00055
Buchanan C, Woolford L, Stephenson T, Hoebergen M, Kovac JH, Breed WG, Speight N. TESTIS ABNORMALITIES IN A POPULATION OF SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS). J Wildl Dis. 2022 Jan 01;58(1):158-167. doi: 10.7589/JWD-D-21-00055. PMID: 34797903.
Copy Download .nbib Format: NLM
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.

Journal for immunotherapy of cancer

Alexander JL, Ibraheim H, Sheth B, Little J, Khan MS, Richards C, Hunter N, Chauhan D, Ratnakumaran R, McHugh K, Pinato DJ, Nathan P, Choy J, Crusz SM, Furness A, Turajlic S, Pickering L, Larkin J, Teare JP, Papa S, Speight A, Sharma A, Powell N.
PMID: 34233964
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002742.

INTRODUCTION: Immune checkpoint inhibitors (CPIs) have changed the treatment landscape for many cancers, but also cause severe inflammatory side effects including enterocolitis. CPI-induced enterocolitis is treated empirically with corticosteroids, and infliximab (IFX) is used in corticosteroid-refractory cases. However, robust...

Cite
Alexander JL, Ibraheim H, Sheth B, et al. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. J Immunother Cancer. 2021;9(7)doi: 10.1136/jitc-2021-002742.
Alexander, J. L., Ibraheim, H., Sheth, B., Little, J., Khan, M. S., Richards, C., Hunter, N., Chauhan, D., Ratnakumaran, R., McHugh, K., Pinato, D. J., Nathan, P., Choy, J., Crusz, S. M., Furness, A., Turajlic, S., Pickering, L., Larkin, J., Teare, J. P., Papa, S., Speight, A., Sharma, A., & Powell, N. (2021). Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. Journal for immunotherapy of cancer, 9(7), . https://doi.org/10.1136/jitc-2021-002742
Alexander, James L, et al. "Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab." Journal for immunotherapy of cancer vol. 9,7 (2021). doi: https://doi.org/10.1136/jitc-2021-002742
Alexander JL, Ibraheim H, Sheth B, Little J, Khan MS, Richards C, Hunter N, Chauhan D, Ratnakumaran R, McHugh K, Pinato DJ, Nathan P, Choy J, Crusz SM, Furness A, Turajlic S, Pickering L, Larkin J, Teare JP, Papa S, Speight A, Sharma A, Powell N. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002742. PMID: 34233964; PMCID: PMC8264884.
Copy Download .nbib Format: NLM
Changes in quality of life following hypoglycaemia in adults with type 2 diabetes: A systematic review of longitudinal studies.

Diabetic medicine : a journal of the British Diabetic Association

Matlock KA, Broadley M, Hendrieckx C, Clowes M, Sutton A, Heller SR, de Galan BE, Pouwer F, Speight J.
PMID: 34596292
Diabet Med. 2022 Jan;39(1):e14706. doi: 10.1111/dme.14706. Epub 2021 Oct 07.

AIM: To conduct a systematic review of published studies reporting on the longitudinal impacts of hypoglycaemia on quality of life (QoL) in adults with type 2 diabetes.METHOD: Database searches with no restrictions by language or date were conducted in...

Cite
Matlock KA, Broadley M, Hendrieckx C, et al. Changes in quality of life following hypoglycaemia in adults with type 2 diabetes: A systematic review of longitudinal studies. Diabet Med. 2021;39(1):e14706doi: 10.1111/dme.14706.
Matlock, K. A., Broadley, M., Hendrieckx, C., Clowes, M., Sutton, A., Heller, S. R., de Galan, B. E., Pouwer, F., Speight, J. (2022). Changes in quality of life following hypoglycaemia in adults with type 2 diabetes: A systematic review of longitudinal studies. Diabetic medicine : a journal of the British Diabetic Association, 39(1), e14706. https://doi.org/10.1111/dme.14706
Matlock, Kevin A, et al. "Changes in quality of life following hypoglycaemia in adults with type 2 diabetes: A systematic review of longitudinal studies." Diabetic medicine : a journal of the British Diabetic Association vol. 39,1 (2022): e14706. doi: https://doi.org/10.1111/dme.14706
Matlock KA, Broadley M, Hendrieckx C, Clowes M, Sutton A, Heller SR, de Galan BE, Pouwer F, Speight J. Changes in quality of life following hypoglycaemia in adults with type 2 diabetes: A systematic review of longitudinal studies. Diabet Med. 2022 Jan;39(1):e14706. doi: 10.1111/dme.14706. Epub 2021 Oct 07. PMID: 34596292.
Copy Download .nbib Format: NLM
An Analysis of Demographic and Triage Assessment Findings in Bushfire-Affected Koalas (.

Animals : an open access journal from MDPI

Dunstan E, Funnell O, McLelland J, Stoeckeler F, Nishimoto E, Mitchell D, Mitchell S, McLelland DJ, Kalvas J, Johnson L, Moore C, Eyre LJM, McLune A, Hough I, Valenza L, Boardman WSJ, Smith I, Speight N.
PMID: 34827969
Animals (Basel). 2021 Nov 12;11(11). doi: 10.3390/ani11113237.

In the 2019-2020 Australian bushfires, Kangaroo Island, South Australia, experienced catastrophic bushfires that burnt approximately half the island, with an estimated 80% of the koala population lost. During and after the event, rescued koalas were triaged at a designated...

Cite
Dunstan E, Funnell O, McLelland J, et al. An Analysis of Demographic and Triage Assessment Findings in Bushfire-Affected Koalas (. Animals (Basel). 2021;11(11)doi: 10.3390/ani11113237.
Dunstan, E., Funnell, O., McLelland, J., Stoeckeler, F., Nishimoto, E., Mitchell, D., Mitchell, S., McLelland, D. J., Kalvas, J., Johnson, L., Moore, C., Eyre, L. J. M., McLune, A., Hough, I., Valenza, L., Boardman, W. S. J., Smith, I., & Speight, N. (2021). An Analysis of Demographic and Triage Assessment Findings in Bushfire-Affected Koalas (. Animals : an open access journal from MDPI, 11(11), . https://doi.org/10.3390/ani11113237
Dunstan, Evie, et al. "An Analysis of Demographic and Triage Assessment Findings in Bushfire-Affected Koalas (." Animals : an open access journal from MDPI vol. 11,11 (2021). doi: https://doi.org/10.3390/ani11113237
Dunstan E, Funnell O, McLelland J, Stoeckeler F, Nishimoto E, Mitchell D, Mitchell S, McLelland DJ, Kalvas J, Johnson L, Moore C, Eyre LJM, McLune A, Hough I, Valenza L, Boardman WSJ, Smith I, Speight N. An Analysis of Demographic and Triage Assessment Findings in Bushfire-Affected Koalas (. Animals (Basel). 2021 Nov 12;11(11). doi: 10.3390/ani11113237. PMID: 34827969; PMCID: PMC8614434.
Copy Download .nbib Format: NLM
Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure.

MDM policy & practice

Thomson MC, Allen LA, Halpern SD, Ko YA, Matlock DD, Mitchell AR, Moore MA, Morris AA, Rao BR, Scherer LD, Speight CD, Ubel PA, Dickert NW.
PMID: 34693019
MDM Policy Pract. 2021 Oct 18;6(2):23814683211041623. doi: 10.1177/23814683211041623. eCollection 2021.

No abstract available.

Cite
Thomson MC, Allen LA, Halpern SD, et al. Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure. MDM Policy Pract. 2021;6(2):23814683211041623doi: 10.1177/23814683211041623.
Thomson, M. C., Allen, L. A., Halpern, S. D., Ko, Y. A., Matlock, D. D., Mitchell, A. R., Moore, M. A., Morris, A. A., Rao, B. R., Scherer, L. D., Speight, C. D., Ubel, P. A., & Dickert, N. W. (2021). Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure. MDM policy & practice, 6(2), 23814683211041623. https://doi.org/10.1177/23814683211041623
Thomson, Mary C, et al. "Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure." MDM policy & practice vol. 6,2 (2021): 23814683211041623. doi: https://doi.org/10.1177/23814683211041623
Thomson MC, Allen LA, Halpern SD, Ko YA, Matlock DD, Mitchell AR, Moore MA, Morris AA, Rao BR, Scherer LD, Speight CD, Ubel PA, Dickert NW. Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure. MDM Policy Pract. 2021 Oct 18;6(2):23814683211041623. doi: 10.1177/23814683211041623. eCollection 2021. PMID: 34693019; PMCID: PMC8529322.
Copy Download .nbib Format: NLM
Chemo-Radiative Stress of Plasma as a Modulator of Charge-Dependent Nanodiamond Cytotoxicity.

ACS applied bio materials

Wang P, Zhou R, Zhou R, Recek N, Prasad K, Speight R, Richard D, Cullen PJ, Thompson EW, Ostrikov KK, Bazaka K.
PMID: 35019378
ACS Appl Bio Mater. 2020 Oct 19;3(10):7202-7210. doi: 10.1021/acsabm.0c01000. Epub 2020 Sep 24.

Efficient and selective internalization of nanoscale diamonds (also termed nanodiamonds, NDs) by living cells is of fundamental importance for their bionanotechnological applications. The biocompatibility of NDs is well established and has been suggested to arise from the limited membrane...

Cite
Wang P, Zhou R, Zhou R, et al. Chemo-Radiative Stress of Plasma as a Modulator of Charge-Dependent Nanodiamond Cytotoxicity. ACS Appl Bio Mater. 2020;3(10):7202-7210doi: 10.1021/acsabm.0c01000.
Wang, P., Zhou, R., Zhou, R., Recek, N., Prasad, K., Speight, R., Richard, D., Cullen, P. J., Thompson, E. W., Ostrikov, K. K., & Bazaka, K. (2020). Chemo-Radiative Stress of Plasma as a Modulator of Charge-Dependent Nanodiamond Cytotoxicity. ACS applied bio materials, 3(10), 7202-7210. https://doi.org/10.1021/acsabm.0c01000
Wang, Peiyu, et al. "Chemo-Radiative Stress of Plasma as a Modulator of Charge-Dependent Nanodiamond Cytotoxicity." ACS applied bio materials vol. 3,10 (2020): 7202-7210. doi: https://doi.org/10.1021/acsabm.0c01000
Wang P, Zhou R, Zhou R, Recek N, Prasad K, Speight R, Richard D, Cullen PJ, Thompson EW, Ostrikov KK, Bazaka K. Chemo-Radiative Stress of Plasma as a Modulator of Charge-Dependent Nanodiamond Cytotoxicity. ACS Appl Bio Mater. 2020 Oct 19;3(10):7202-7210. doi: 10.1021/acsabm.0c01000. Epub 2020 Sep 24. PMID: 35019378.
Copy Download .nbib Format: NLM
How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study.

Diabetes technology & therapeutics

Schipp J, Skinner T, Holloway E, Scibilia R, Langstrup H, Speight J, Hendrieckx C.
PMID: 33720767
Diabetes Technol Ther. 2021 Aug;23(8):546-554. doi: 10.1089/dia.2020.0652. Epub 2021 Apr 05.

No abstract available.

Cite
Schipp J, Skinner T, Holloway E, et al. How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study. Diabetes Technol Ther. 2021;23(8):546-554doi: 10.1089/dia.2020.0652.
Schipp, J., Skinner, T., Holloway, E., Scibilia, R., Langstrup, H., Speight, J., & Hendrieckx, C. (2021). How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study. Diabetes technology & therapeutics, 23(8), 546-554. https://doi.org/10.1089/dia.2020.0652
Schipp, Jasmine, et al. "How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study." Diabetes technology & therapeutics vol. 23,8 (2021): 546-554. doi: https://doi.org/10.1089/dia.2020.0652
Schipp J, Skinner T, Holloway E, Scibilia R, Langstrup H, Speight J, Hendrieckx C. How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study. Diabetes Technol Ther. 2021 Aug;23(8):546-554. doi: 10.1089/dia.2020.0652. Epub 2021 Apr 05. PMID: 33720767.
Copy Download .nbib Format: NLM
Showing 121 to 128 of 128 entries